Evaluating Different Methods of Circulating Tumor DNA Quantification in Oncology Patients
T
Tim Lautenschlaeger, MD
Primary Investigator
Overview
This study aims to invent a test that can see tiny pieces from people with cancer (specifically DNA from a person’s cancer) in blood and urine better than tests that can currently be done. In the future, this test can possibly be used to find a small cancer before other tests can find it.
Description
Participants will be asked to complete a 24 hour urine collection. Participants may be asked to complete a blood draw and some swab samples. Samples will be collected throughout the participant's cancer treatment journey. Researchers will ask permission to access participants' medical records for up to 10 years.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
HPV, Human papillomavirus
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
- Healthy individuals, patients with cancer, and patients with Hepatitis C
- Cancer patients who plan to undergo therapy
- Patients with Hepatitis C with a recent positive test
- Ability to provide written informed consent and HIPAA authorization
Exclusion Criteria:
- Dialysis dependent
Updated on
30 Apr 2024.
Study ID: 11731, CTO-IUSCCC-0769
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
